456
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia

, , , &
Pages 541-546 | Received 30 Jan 2012, Accepted 27 Jul 2012, Published online: 22 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Etan Orgel, Nicole M. Mueske, Richard Sposto, Vicente Gilsanz, David R. Freyer & Steven D. Mittelman. (2018) Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy. Leukemia & Lymphoma 59:1, pages 138-145.
Read now
Xi Xu, Qianying Zhang, Gang Hu, Qiang Zhuang, Chongyun Xing, Yifen Shi, Bin Liang, Zhijian Shen, Songfu Jiang, Kang Yu & Jianhua Feng. (2018) Effect of initial body mass index on survival outcome of patients with myelodysplastic syndrome: a single-center retrospective study. Leukemia & Lymphoma 59:1, pages 129-137.
Read now
Sally Mapp, Geeta Sandhu, Christine Carrington & Stefanie Hennig. (2016) A systematic review of treatment outcomes with weight-based dosing of chemotherapy in obese adult patients with acute leukemia or lymphoma. Leukemia & Lymphoma 57:4, pages 981-984.
Read now

Articles from other publishers (27)

James M. Foran, Zhuoxin Sun, Catherine Lai, Hugo F. Fernandez, Larry D. Cripe, Rhett P. Ketterling, Janis Racevskis, Selina M. Luger, Elisabeth Paietta, Hillard M. Lazarus, Yanming Zhang, John M. Bennett, Ross L. Levine, Jacob M. Rowe, Mark R. Litzow & Martin S. Tallman. (2023) Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis. Cancer 129:16, pages 2479-2490.
Crossref
Julius C. Enßle, Sebastian Wolf, Sebastian Scheich, Sarah Weber, Michael Kramer, Leo Ruhnke, Christoph Schliemann, Jan-Henrik Mikesch, Stefan Krause, Tim Sauer, Maher Hanoun, Hans Christian Reinhardt, Sabrina Kraus, Martin Kaufmann, Mathias Hänel, Lars Fransecky, Andreas Burchert, Andreas Neubauer, Martina Crysandt, Edgar Jost, Dirk Niemann, Kerstin Schäfer-Eckart, Gerhard Held, Ulrich Kaiser, Maxi Wass, Markus Schaich, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D. Baldus, Martin Bornhäuser, Christoph Röllig, Hubert Serve & Björn Steffen. (2023) Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience. British Journal of Cancer.
Crossref
Ji In Park, Yu Kyung Lee, Eun Hyung Koo, So Hee Lee, Ae Ryoung Park, Jeong Yi Yoon, Jin Suk Kang & Sylvia Park. (2023) Efficacy and Safety of Chemotherapy Dosed on Actual or Adjusted Body Weight in Obese Patients with Leukemia. Journal of Korean Society of Health-System Pharmacists 40:1, pages 47-58.
Crossref
Daniel Tuyet Kristensen, Lars Børty Nielsen, Lasse Hjort Kyneb Jakobsen, Tove‐Christina Choe Kristensen, Lene Østergaard Jepsen, Claudia Schöllkopf, Kim Theilgaard‐Mönch, Tarec Christoffer El‐Galaly, Anne Stidsholt Roug & Marianne Tang Severinsen. (2022) Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study. British Journal of Haematology 199:4, pages 539-548.
Crossref
Igor М. Skrypnyk, Ganna S. Maslova, Tetiana V. Lymanets & Roman І. Skrypnyk. (2022) THE OVERWEIGHT AND OBESITY ROLE IN THE OCCURRENCE OF CHEMOTHERAPY-INDUCED HEPATOTOXIC REACTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. Wiadomości Lekarskie 75:6, pages 1506-1511.
Crossref
I. M. SkrypnykG. S. MaslovaT. V. Lymanets. (2022) OVERWEIGHT AND OBESITY AS RISK FACTORS FOR CHEMOTHERAPY-INDUCED HEPATOTOXICITY IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA. World of Medicine and Biology 18:80, pages 146.
Crossref
Jennifer J. Griggs, Kari Bohlke, Edward P. Balaban, James J. Dignam, Evan T. Hall, R. Donald Harvey, Diane P. Hecht, Kelsey A. Klute, Vicki A. Morrison, T. May Pini, Gary L. Rosner, Carolyn D. Runowicz, Michelle Shayne, Alex Sparreboom, Sophia Turner, Corrine Zarwan & Gary H. Lyman. (2021) Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. Journal of Clinical Oncology 39:18, pages 2037-2048.
Crossref
Prajwal Dhakal, Elizabeth Lyden, Andrea Lee, Joel Michalski, Zaid S. Al-Kadhimi, Lori J. Maness, Krishna Gundabolu & Vijaya Raj Bhatt. (2020) Effects of Obesity on Overall Survival of Adults With Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 20:3, pages e131-e136.
Crossref
Lauren Dombrowski & Leila Mohassel. (2018) Outcomes in obese patients undergoing induction therapy for acute leukemia. Journal of Oncology Pharmacy Practice 25:5, pages 1058-1065.
Crossref
Lauriane Filliatre‐Clement, Julien Broseus, Marc Muller, Kossar Hosseini, Christine Rotonda, Luciane Schirmer, Gabrielle Roth‐Guepin, Caroline Bonmati, Pierre Feugier, Marie‐Christine Béné & Aurore Perrot. (2018) Serum albumin or body mass index: Which prognostic factor for survival in patients with acute myeloblastic leukaemia?. Hematological Oncology 37:1, pages 80-84.
Crossref
Sotirios G. Papageorgiou, Ioannis Kotsianidis, Christos K. Kontos, Argyris Symeonidis, Athanasios Galanopoulos, Eleftheria Hatzimichael, Elias Poulakidas, Panagiotis Diamantopoulos, Theodoros P. Vassilakopoulos, Panagiotis Zikos, Helen Papadaki, Eleni Bouronikou, Panayiotis Panayiotidis, Nora-Athina Viniou & Vasiliki Pappa. (2018) Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group. Leukemia Research 71, pages 55-59.
Crossref
Vicki A. Morrison, Linda McCall, Hyman B. Muss, Aminah Jatoi, Harvey J. Cohen, Constance T. Cirrincione, Jennifer A. Ligibel, Jacqueline M. Lafky & Arti Hurria. (2018) The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436). Journal of Geriatric Oncology 9:3, pages 228-234.
Crossref
Shufen Li, Li Chen, Wen Jin, Xuefei Ma, Yunlin Ma, Fangyi Dong, Hongming Zhu, Junmin Li & Kankan Wang. (2017) Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis. Scientific Reports 7:1.
Crossref
Maria Helena Faria Ornellas, Maria Christina Paixão Maioli, Stella Beatriz Sampaio Gonçalves de Lucena, Elenice Ferreira Bastos, Tatiana Silva Chaves, Karina Vieira de Melo, Marilza de Moura Ribeiro-Carvalho, Thomas Liehr & Gilda Alves. (2017) Complex karyotype including ring chromosome 11 in a patient with acute myeloid leukemia: case report. Sao Paulo Medical Journal 136:4, pages 361-367.
Crossref
Xavier Cahu, Martin Carré, Christian Recher, Arnaud Pigneux, Mathilde Hunault-Berger, Norbert Vey, Patrice Chevallier, Jacques Delaunay, Emmanuel Gyan, Bruno Lioure, Caroline Bonmati, Chantal Himberlin, Yosr Hicheri, Gaelle Guillerm, Bouscary Didier, Fabrice Larosa, Mario Ojeda-Uribe, Marc Bernard, Marie C. Bene, Norbert Ifrah & Jean-Yves Cahn. (2017) Impact of body-surface area on patients’ outcome in younger adults with acute myeloid leukemia. European Journal of Haematology 98:5, pages 443-449.
Crossref
Martina Crysandt, Michael Kramer, Gerhard Ehninger, Martin Bornhäuser, Wolfgang E. Berdel, Hubert Serve, Christoph Röllig, Andrea Kaifie, Edgar Jost, Tim H. Brummendorf & Stefan Wilop. (2016) A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia . European Journal of Haematology 97:1, pages 17-24.
Crossref
Etan Orgel, Jeanine M Genkinger, Divya Aggarwal, Lillian Sung, Michael Nieder & Elena J Ladas. (2016) Association of body mass index and survival in pediatric leukemia: a meta-analysis. The American Journal of Clinical Nutrition 103:3, pages 808-817.
Crossref
E. Orgel. 2016. Handbook of nutrition and diet in leukemia and blood disease therapy. Handbook of nutrition and diet in leukemia and blood disease therapy 335 352 .
Suzanne Tavitian, Am?lia Denis, Fran?ois Vergez, Emilie Berard, Audrey Sarry, Anne Huynh, Eric Delabesse, Isabelle Luquet, Fran?oise Huguet, Christian R?cher & Sarah Bertoli. (2016) Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy. American Journal of Hematology 91:2, pages 193-198.
Crossref
Whitney M. Bray, Cory Bivona, Michelle Rockey, Dave Henry, Dennis Grauer, Sunil Abhyankar, Omar Aljitawi, Siddhartha Ganguly, Joseph McGuirk, Anurag Singh & Tara L. Lin. (2015) Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight. Cancer Chemotherapy and Pharmacology 76:4, pages 691-697.
Crossref
Ma?l Heiblig, Mohamed Elhamri, Franck E. Nicolini, Eric Wattel, Mauricette Michallet, Gilles Salles & Xavier Thomas. (2015) Effect of Initial Body Mass Index on Survival Outcome of Patients With Acute Leukemia: A?Single-Center Retrospective Study. Clinical Lymphoma Myeloma and Leukemia 15, pages S7-S13.
Crossref
Kaylene M. Peric & David J. Reeves. (2015) Tolerability of induction chemotherapy dosing practices in acute myeloid leukemia patients. Leukemia Research 39:2, pages 173-176.
Crossref
Mary-Elizabeth M. Percival & Bruno C. Medeiros. (2015) Chemotherapy dose in obese AML patients: To cap or not to cap?. Leukemia Research 39:1, pages 30-32.
Crossref
Jonathan Tucci & Steven D. Mittelman. 2015. Murine Models, Energy Balance, and Cancer. Murine Models, Energy Balance, and Cancer 97 116 .
Emmanuelle Kempf, Pierre Hirsch, Myriam Labopin, Frank Viguié, Françoise Isnard, Ruoping Tang, Christophe Marzac, Jean Pierre Marie, Mohamad Mohty & Ollivier Legrand. (2014) Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia. Leukemia Research 38:12, pages 1425-1429.
Crossref
Candice M. Wenzell, Erika M. Gallagher, Marc Earl, Jun-Yen Yeh, Karissa N. Kusick, Anjali S. Advani, Matt E. Kalaycio, Sudipto Mukherjee, Ramon V. Tiu, Jaroslaw P. Maciejewski & Mikkael A. Sekeres. (2013) Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight. American Journal of Hematology 88:10, pages 906-909.
Crossref
Fuad El RassiMartha Arellano. (2013) Update on Optimal Management of Acute Myeloid Leukemia. Clinical Medicine Insights: Oncology 7, pages CMO.S8528.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.